Warby Parker (WRBY) Other Non-Current Assets (2020 - 2026)
Warby Parker's (WRBY) quarterly Other Non-Current Assets came in at $12.1 million in Q1 2026, up 48.27% YoY from $8.2 million in Q1 2025, and up 18.48% on a QoQ basis from $10.2 million in Q4 2025.
Warby Parker (WRBY) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Warby Parker (WRBY) has 7 years of Other Non-Current Assets data on file, last reported at $12.1 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 48.27% year-over-year to $12.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.1 million (up 48.27% YoY) and the FY2025 annual result came in at $10.2 million, up 17.62% from the prior year.
- Other Non-Current Assets climbed to $12.1 million in Q1 2026, from $10.2 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $12.1 million in Q1 2026 to a low of $1.5 million in Q1 2022.
- A 5-year average of $8.0 million and a median of $8.5 million in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 1704.03% — and 2025, when it declined 22.1%.
- Tracing WRBY's Other Non-Current Assets over 5 years: stood at $8.5 million in 2022, then slipped by 16.96% to $7.1 million in 2023, then climbed by 23.24% to $8.7 million in 2024, then climbed by 17.62% to $10.2 million in 2025, then rose by 18.48% to $12.1 million in 2026.
- The last three Other Non-Current Assets figures came in at $12.1 million (Q1 2026), $10.2 million (Q4 2025), and $8.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Warby Parker | 3.41 Bn | 3.12 Bn | 136.46 Mn | 13.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.37 Mn |
| Mar 31, 2026 | 12.12 Mn |
| Dec 31, 2025 | 10.23 Mn |
| Sep 30, 2025 | 8.78 Mn |
| Jun 30, 2025 | 8.41 Mn |
| Mar 31, 2025 | 8.17 Mn |
| Dec 31, 2024 | 8.70 Mn |
| Sep 30, 2024 | 8.73 Mn |
| Jun 30, 2024 | 8.70 Mn |
| Mar 31, 2024 | 10.49 Mn |
| Dec 31, 2023 | 7.06 Mn |
| Sep 30, 2023 | 7.93 Mn |
| Jun 30, 2023 | 7.71 Mn |
| Mar 31, 2023 | 9.57 Mn |
| Dec 31, 2022 | 8.50 Mn |
| Sep 30, 2022 | 5.80 Mn |
| Jun 30, 2022 | 3.81 Mn |
| Mar 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | 471,000.00 |
| Sep 30, 2021 | 739,000.00 |